Dalbavancin
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for Dalbavancin, covering 2016-09-23 to 2025-11-26. Get the full timeline:
Most recent: FDA Approved: DALBAVANCIN — Original Application (Meitheal Pharmaceuticals Inc)